7.89

14.15% -1.30

After Hours: 7.97 0.08 +1.01%

Accolade Inc (ACCD)

Overview News Price History Option Chain Why ACCD Down? Discussions Forecast

Accolade Inc stock is currently priced at $7.89, with a 24-hour trading volume of 1.49M. It has seen a -14.15% decreased in the last 24 hours and a -20.78% declined in the past month. The chart indicates a potential bearish trend, as the stock is below the $9.15 pivot point. If it approaches the $8.35 support level, significant changes may occur.

Previous Close:

$9.19

Open:

$7.87

24h Volume:

1.49M

Market Cap:

$610.75M

Revenue:

$388.49M

Net Income/Loss:

$-122.73M

P/E Ratio:

-4.0779

EPS:

-1.9348

Net Cash Flow:

$-37.47M

1W Performance:

-13.58%

1M Performance:

-20.78%

6M Performance:

+19.73%

1Y Performance:

-50.69%

1D Range:

$7.6205

$8.58

52W Range:

$6.33

$17.00

Accolade Inc Stock (ACCD) Company Profile

Name

Accolade Inc

Sector

Healthcare (1191)

Industry

Health Information Services (62)

Phone

610-834-2989

Address

660 West Germantown Pike, Suite 500, Plymouth Meeting

Employee

1,250

Twitter

Next Earnings Date

2024-04-25

Latest SEC Filings

ACCD's Discussions on Twitter

Accolade Inc Stock (ACCD) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-17-24	Resumed	DA Davidson	Neutral
Jan-03-24	Initiated	Barclays	Equal Weight
May-24-23	Upgrade	BofA Securities	Neutral → Buy
Apr-12-23	Initiated	Stephens	Overweight
Mar-23-23	Upgrade	Guggenheim	Neutral → Buy
Feb-09-23	Downgrade	Jefferies	Buy → Hold
Feb-02-23	Initiated	Raymond James	Outperform
Sep-08-22	Resumed	Piper Sandler	Overweight
Sep-07-22	Initiated	Truist	Buy
Aug-12-22	Initiated	DA Davidson	Buy
May-02-22	Upgrade	Wells Fargo	Underweight → Equal Weight
Apr-29-22	Downgrade	BTIG Research	Buy → Neutral
Apr-29-22	Downgrade	BofA Securities	Buy → Neutral
Apr-29-22	Downgrade	Credit Suisse	Outperform → Neutral
Apr-29-22	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Apr-29-22	Downgrade	SVB Leerink	Outperform → Mkt Perform
Apr-11-22	Initiated	Wells Fargo	Underweight
Apr-07-22	Initiated	Guggenheim	Neutral
Apr-01-22	Resumed	Credit Suisse	Outperform
Feb-11-22	Initiated	Goldman	Buy
Dec-02-21	Initiated	Jefferies	Buy
Sep-30-21	Initiated	Berenberg	Buy
Sep-17-21	Upgrade	Robert W. Baird	Neutral → Outperform
May-28-21	Initiated	Robert W. Baird	Neutral
May-06-21	Upgrade	SVB Leerink	Mkt Perform → Outperform
Apr-15-21	Initiated	Needham	Buy
Mar-11-21	Resumed	Goldman	Buy
Jan-15-21	Upgrade	Credit Suisse	Neutral → Outperform
Jan-07-21	Initiated	BTIG Research	Buy
Dec-08-20	Initiated	Canaccord Genuity	Buy
Sep-22-20	Initiated	DA Davidson	Buy
Jul-27-20	Initiated	BofA Securities	Buy
Jul-27-20	Initiated	Credit Suisse	Neutral
Jul-27-20	Initiated	Goldman	Buy
Jul-27-20	Initiated	Morgan Stanley	Overweight
Jul-27-20	Initiated	Piper Sandler	Overweight
Jul-27-20	Initiated	Robert W. Baird	Outperform
Jul-27-20	Initiated	SVB Leerink	Outperform

View All

Accolade Inc Stock (ACCD) Latest News

Accolade Inc Stock (ACCD) Financials Data

Accolade Inc (ACCD) Revenue 2024

ACCD reported a revenue (TTM) of $388.49 million for the quarter ending November 30, 2023, a +8.55% rise year-over-year.

Accolade Inc (ACCD) Net Income 2024

ACCD net income (TTM) was -$122.73 million for the quarter ending November 30, 2023, a +73.54% increase year-over-year.

Accolade Inc (ACCD) Cash Flow 2024

ACCD recorded a free cash flow (TTM) of -$37.47 million for the quarter ending November 30, 2023, a +18.45% increase year-over-year.

Accolade Inc (ACCD) Earnings per Share 2024

ACCD earnings per share (TTM) was -$1.6548 for the quarter ending November 30, 2023, a +75.12% growth year-over-year.

Accolade, Inc. develops and provides technology-enabled solutions that help people understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and with multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. Its customers are primarily employers who provide their employees and their employees' families a single place to turn for their health, healthcare, and benefits needs. Accolade, Inc. was founded in 2007 and is headquartered in Plymouth Meeting, Pennsylvania.